Abstract
The optimized enhanced recovery after surgery (ERAS) pathway in patients with early onset scoliosis (EOS) has not yet been comprehensively described. This study explored the efficacy and feasibility of an integral process of the ERAS pathway in posterior spinal fusion (PSF) surgery in EOS patients. A total of 70 patients were included in this study, with 35 patients receiving treatment using an ERAS pathway designed and implemented by a multidisciplinary team. The remaining 35 patients followed the traditional pathway (TP) perioperative care. Patient demographics, radiographic parameters, surgical data, and clinical information were collected and analyzed retrospectively. There were no significant differences in sex, height, weight, age, body mass index, preoperative hemoglobin level, fusion segments, number of screws, Cobb angle of the main curve, or surgical duration between the ERAS and TP groups. Regarding pain intensity, the estimated blood loss (EBL), first ambulation time, length of analgesic use, postoperative length of stay (LOS), drainage duration, drainage volume, and incidence of blood transfusion were significantly lower in the ERAS group than in the TP group. The ERAS pathway in EOS orthopedic surgery effectively reduces intraoperative bleeding, alleviates postoperative pain, reduces complications, accelerates recovery, and shortens hospital stays. Therefore, spinal surgeons should adopt the ERAS pathway in EOS surgery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Sichuan University Ethics committee gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Supplental tables were provided
Data Availability
All data produced in the present study are available upon reasonable request to the authors.